Jennifer Dashnau

Company: Century Therapeutics

Job title: Vice President - Analytical Development & Quality Control

Seminars:

Panel: How Do Characterization Approaches Differ Between Cell Types to Manage Complexity in Cell Differences 12:00 pm

Taking learnings from CAR-T to inform product characterization Optimizing analytical development for Gamma Delta, NK and iPSC derived products Determining the technologies required for automation and high-throughput characterization of different cell typesRead more

day: Day 2 Track C

Diving Into Analytical Development for iPSC-derived Products to Actualize the Promise of These Cell Types 10:30 am

With the unmatched clinical potential of iPSCs, it is important to fully characterize and understand your product. Dive into the nuances and important considerations for tool selection and iPSC analytical development Key discussion points: Benchmarking pivotal technologies for process analytics of stem cell based products Investigating the importance of analytical tools for differentiation in iPSC…Read more

day: Workshop D